Agencourt Bioscience, the leading commercial DNA Sequencing services provider, is offering a new portfolio of genomic services to include massively parallel sequencing technologies. Utilizing a cross platform strategy to merge the strengths of various platforms, we are now offering services on the Roche 454 GS-FLX¹ and Applied Biosystems SOLiD¹ platforms. By offering these new technologies, we can utilize new applications and hence expand the tools available to our customers. We have the ability to harness the power of the technology and increase cost savings by using next generation sequencing. Agencourt's value-added services and packaged solutions provide a strong complement to these new innovations.
Our complementary services can provide:
- Upstream fragment library construction for various insert sizes and applications
- Custom and novel cDNA library construction and pooling techniques
- Integration of our patented SPRI® magnetic bead sample prep methodology
- Streamlined and standardized sample prep on our Biomek® FX and automation solutions
- Integration and secured management of customer data using our custom Oracle-based Laboratory Information Management Systems (LIMS)
- Complementary bioinformatics services for assembly, data packaging and analysis
- Excess Sanger sequencing capacity for Genome finishing and hybrid strategies
- Genome Annotation and Pathway reconstruction using ERGO¹
Key technology features:
- Obtain up to 100Mb or 3Gb of easy-to-map data per run
- Single molecule or clonal amplification of templates to avoid cloning bias
- Ability to run up to 16 samples on separate channels
- Mated paired end libraries
- 35 to 250 bp of high quality read lengths depending on the platform and application
- Robust chemistry for accurate base-calling
Next Generation Sequencing Applications
|
Whole Genome Analysis
|
|
Transcriptome Analysis
|
|
RNA Analysis
|
|
Structural Variation Analysis
|
¹ Trademarks are property of their respective owners.


